Abstract
The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g., liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches.
| Original language | English |
|---|---|
| Pages (from-to) | 2557-2575 |
| Number of pages | 19 |
| Journal | Journal of Pharmaceutical Sciences |
| Volume | 99 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2010 |
Keywords
- Hyperglycosylation
- Liposomes
- PEGylation
- Poly(lactic/glycolic) acid
- Protein delivery
Fingerprint
Dive into the research topics of 'Delivery of therapeutic proteins'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver